News & Views

  • Collaboration to Develop Point-of-Care LFA Tests
    Dr Heikki Lanckriet

Collaboration to Develop Point-of-Care LFA Tests

Aug 19 2019 Read 337 Times

A commercial agreement to address limitations in development of complex, multiplex point-of-care (POC) lateral flow assay (LFA) diagnostic tests has been announced by Expedeon AG and Canadian company Sona Nanotech Inc.

Under the terms of the agreement, Expedeon will provide gold nanoparticle, bioconjugation technologies and expertise and Sona will offer its lateral flow assay development services. The collaboration will enable the rapid development of more complex / multiplex immunoassays into LFAs, from proof of principle, through scale-up and transfer to manufacturing.

The lateral flow assay market which is predicted to reach US$8.7 billion over the next four years comprises several stakeholders such as raw material suppliers, processors, end-product manufacturers, distributors, and regulatory organisations in the supply chain. The demand for this market is characterised by the hospitals & clinics, diagnostic laboratories, home care, food & beverage, pharmaceutical, nutraceutical & biotechnology companies, and the environmental testing industry. A significant portion of this market is comprised of POC diagnostics.

Dr Heikki Lanckriet, CEO, Expedeon AG, said: "The adoption of point-of-care diagnostics is increasing globally, due to factors such as high prevalence of infectious diseases in developing countries, increasing incidence of target diseases, and rising preference for home healthcare. Despite the growing market, there are several bottlenecks in the development of point of care assays. We are looking forward to working with Sona to overcome these challenges, without compromising on quality or reproducibility."

Darren Rowles, President and CEO, Sona Nanotech, commented: "Signing this agreement with Expedeon further strengthens the productive partnership between our organisations and our commitment to delivering value to our combined global customer base."

Reader comments

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Post a Comment




Digital Edition

Labmate UK & Ireland September 2019

September 2019

Articles Finding an easy, cost-effective way to break into new markets Exploring safe and intelligent multi-application liquid nitrogen cooling via auto-fill technology Characterisation o...

View all digital editions

Events

Analytica Anacon India & IndiaLabExpo

Sep 19 2019 Hyderabad, India

16th Confocal Raman Imaging Symposium

Sep 23 2019 Ulm Germany

Analitica Latin America

Sep 24 2019 Sao Paulo, Brazil

Pharma Asia

Sep 24 2019 Karachi, Pakistan

ILMAC

Sep 24 2019 Basel, Switzerland

View all events